The entitlement of veterans affairs medical patients to vulnerable population status for human

McGuire, Elizabeth R.
June 1992
Health Matrix: Journal of Law-Medicine;Summer92, Vol. 2 Issue 2, p259
Academic Journal
Focuses on whether those who regularly depend on the veterans affairs (VA) system for their medical care should be classified as a vulnerable population. Question if such people deserve additional protection designed to fully insure their informed consent to participation in human medical research; Ethical use of humans in medical research.


Related Articles

  • Deception in the Single-Blind Run-In Phase of Clinical Trials. Mann, Howard // IRB: Ethics & Human Research;Mar/Apr2007, Vol. 29 Issue 2, p14 

    The article discusses the use of deception in the single-blind run-in phase of clinical trials. Although deception in clinical trials is justifiable, its involvement in obtaining informed consent has been subjected to critical appraisal. Furthermore, the author also provides an assessment on...

  • Globalized Clinical Trials and Informed Consent. Annas, George J. // New England Journal of Medicine;5/14/2009, Vol. 360 Issue 20, p2050 

    The article explores ethical and legal aspects of clinical research trials in developing countries and the principles for international research outlined in the 1947 Nuremberg Code and the 1964 Declaration of Helsinki. The author raises questions about whether the codes are followed and their...

  • Informed Consent: Practices and Views of Investigators in a Multinational Clinical Trial. Sabik, Lindsay; Pace, Christine A.; Forster-Gertner, Heidi P.; Wendler, David; Bebchuk, Judith D.; Tavel, Jorge A.; McNay, Laura A.; Killen, Jack; Emanuel, Ezekiel J.; Grady, Christine // IRB: Ethics & Human Research;Sep/Oct2005, Vol. 27 Issue 5, p13 

    The article focuses on a survey of multinational sample of investigators, which determines how much time they dedicate to the consent process, what aspects of the clinical trials they emphasize during the consent process, and what they think about the effectiveness of that process. Although...

  • How Should We Communicate the Likelihood of Risks to Inform Decisions about Consent? Rector, Thomas S. // IRB: Ethics & Human Research;Jul/Aug2008, Vol. 30 Issue 4, p15 

    The article focuses on the potential risks of research participation during the informed consent process and the identification of adverse effects to potential research subjects. It determined several contextual factors that can contribute to variation in the adverse effects such as...

  • Is Longer Always Better? Emanuel, Ezekiel J.; Grady, Christine // Hastings Center Report;May/Jun2008, Vol. 38 Issue 3, p10 

    The authors examine whether the institutional review board should agree and let full informed consent be waived in a randomized clinical trial. They assert that a study that seeks to empirically assess whether a more concise consent document improves research participants' understanding poses no...

  • The Problem with Optimism in Clinical Trials. Jansen, Lynn A. // IRB: Ethics & Human Research;Jul/Aug2006, Vol. 28 Issue 4, p13 

    The author reflects on the phenomenon of "unrealistic optimism" in clinical research compromising informed consent. She argues that its implications for the ethics of clinical research have not been fully appreciated and the phenomenon may be more difficult to address than either the therapeutic...

  • Informed Consent and the Elusive Dichotomy Between Standard and Experimental Therapy. Noah, Lars // American Journal of Law & Medicine;2002, Vol. 28 Issue 4, p361 

    Focuses on the issue of informed consent in medical care as applied to human experimentation. Application of the treatment-research dichotomy; Distinction of experimentation; Desirability of competing formulations of the informed consent rules; Author's asserion of the need for closer attention...

  • Nuremberg Code�Directives for Human Experimentation.  // Applied Clinical Trials;Dec2001, Vol. 10 Issue 12, p44 

    Provides information in Nuremberg Code-Directives for Human Experimentation. Importance of the voluntary consent of the human subject; Goal of the experiment; Termination of the experiment by the human subject.

  • Beyond Nuremberg. Barnes, Patricia G. // ABA Journal;Mar1997, Vol. 83 Issue 3, p24 

    Focuses on the debate on informed consent on human experimentation in medicine in the United States. Features of the Nuremberg Code on human experimentation; Features of the ruling by a New York State appeals court invalidating state regulations allowing surrogates to give consent on behalf of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics